# HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women

> **NCT01315353** · NA · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 467 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **PROCEDURE:** Cervical Cryotherapy
- **PROCEDURE:** Loop Electrosurgical Excision Procedure (LEEP)

## Key facts

- **NCT ID:** NCT01315353
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-04
- **Primary completion:** 2017-02-01
- **Final completion:** 2017-02-01
- **Target enrollment:** 467 (ACTUAL)
- **Last updated:** 2018-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01315353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01315353, "HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01315353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*